The UK is witnessing a growing surge in interest surrounding entheogenic substances. Beyond the common use of psilocybin and LSD, researchers and adventurers are increasingly focused on less-charted frontiers, particularly the copyright compound and the budding cannabinoid, CBG compound. This burgeoning community encompasses clinical trials into… Read More